OTC and FDA Registration
Monday, October 19, 2020
KADCYLA (ado-trastuzumab emtansine) injection, powder, lyophilized, for solution [Genentech, Inc.]
Updated Date: Tue, 13 Oct 2020 00:00:00 EDT
from
https://fda.report/DailyMed/23f3c1f4-0fc8-4804-a9e3-04cf25dd302e7
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment